📈 Biotech Breakouts Ahead? 5 Stocks Poised to Crush the Market 💉

Stocks pulled back Thursday as investors continued rotating out of technology shares, sending the Dow Jones Industrial Average down 311 points (0.6%), the S&P 500 off 1%, and the Nasdaq Composite lower by 1.7%.

The shift away from high-valued tech and AI names like Nvidia, Broadcom, and Alphabet weighed on the Nasdaq, now facing a third straight day of losses.

Meanwhile, Disney tumbled 8% on mixed quarterly results. Despite tech weakness, value sectors such as health care outperformed, pushing the Dow above 48,000 for the first time and setting it up for its best week since June.

Markets also reacted to the end of the six-week U.S. government shutdown, with the newly signed funding bill expected to support short-term stability. However, the blackout of key economic data has clouded the outlook for the Federal Reserve’s next move, though investors remain split on whether a December rate cut is coming.

Top Movers: Under $10 

TNL Mediagene (TNMG) is up 53.54% today to trade at the current level of $0.46. This comes after the company announced it has launched a strategic partnership with U.S. technology company Coupang, Inc., specifically for the Taiwan market to jointly expand its Content Commerce and Retail Media Network ecosystem.

Clearmind Medicine Inc (CMND) zoomed 25.65% in today’s trade to $0.39 after announcing that it has received final approval from the Hadassah Medical Center, Jerusalem, Israel, for its ongoing Phase 1/2a clinical trial evaluating CMND-100, a proprietary MEAI-based oral drug candidate, for the treatment of Alcohol Use Disorder (AUD).

In current trading, Outlook Therapeutics Inc (OTLK) stock is at $1.57 after announcing acceptance of biologics license application by U.S. FDA for ONS-5010 as a treatment for Wet AMD.

Intellicheck Inc (IDN) rose 21.26% in the early hours of today's trading to move at $1.54. The company announced record third-quarter 2025 financial results.

In the current trading session, Broadwind Inc (BWEN) jumped 23.29% to $2.7 over a previous close of $2.19 after announcing third quarter 2025 results.

Ex-Dividend Stocks

ArcBest Corp (ARCB) is about to trade ex-dividend tomorrow, meaning that investors who buy the stock after tomorrow will not be eligible for the next dividend payment. The company's next dividend payment will be $0.12 per share. It has fixed November 14 as the record date for the same and will pay the actual dividend on November 28. Last year, the company distributed a total of $0.48 to its shareholders. Based on the last year's worth of payments, ARCB has a trailing yield of 0.73% on the current stock price of $65.78.

Another stock that is shelling out dividends tomorrow is Bankfinancial Corp (BFIN), having a market capitalization of $142.92M. It will pay a dividend of $0.1 per share, the payment date of which is November 28. Currently, the stock is trading at a trailing dividend yield of 3.49%.

Shares of ConnectOne Bancorp Inc (CNOB) will be the talk of the stock market on Friday as the stock will turn ex-dividend. The company's next dividend payment will be $0.18 per share, and in the last 12 months, it paid a total of $0.72 per share. Last year's total dividend payments show that CNOB has a trailing yield of 2.93% on the current share price of $24.55.

Capital Southwest Corp (CSWC) is also set to go ex-dividend tomorrow. The next dividend payment from CSWC will amount to $0.25 per share. December 15 has been designated as the record date for this dividend, with the actual payout scheduled for December 31. In the previous year, CSWC distributed a total of $2.56 to its valued shareholders. Considering the cumulative dividend payments from last year, the trailing yield for CSWC stands at 12.27% based on the current stock price of $20.89.

Cintas Corporation (CTAS) will be paying out a dividend of $0.45 per share to shareholders holding their shares as of the close of the business hours on the record date of November 14. Over the past 12 months, CTAS has paid out a total of $1.62 per share in dividends. Based on the total dividends paid out last year, CTAS boasts an impressive trailing yield of 0.87% on the current share price of $186.39.

Crypto Market Highlights

• OKX expands into decentralized finance, allowing US users to trade tokens directly on decentralized markets.

• Circle enters the foreign-exchange market, aiming to use stablecoins to modernize traditional finance systems.

• Singapore’s central bank plans to tighten regulations on unregulated stablecoins to safeguard financial integrity.

• Japan’s largest stock-exchange operator considers new restrictions on listed companies that shift their core business into crypto holdings, signaling a change for digital-asset treasury firms.

• US President Donald Trump signs a funding bill ending the record 43-day government shutdown, following its passage in the House of Representatives.

Most Shorted Stocks

Teck Resources Ltd (NNE) was one of the most shorted stocks as of the latest short interest figures, with 36.66% short interest. The days to cover ratio, a measure of how long it would take for all the short positions to be covered based on average trading volume, is 3.3. This represents a change of 1209573 shares, which corresponds to a 10.82% increase in short interest. The total value of the shares held short is estimated to be around $431.74 million. The average daily volume stands at 3.75M shares, and the market capitalization of the company is $1.75B.

The SoundHound AI Inc with the symbol SOUN currently has a short interest of 27.76%. The short interest has changed by -48114 shares. The days to cover ratio stands at 3.0. The estimated value of the shares held short is approximately $1.31 billion. On an average day, 56.93M shares are traded, with the company's market capitalization totaling $5.34B.

For the stock UroGen Pharma Ltd (URGN), the current short interest is at 25.29%. This represents a significant short interest change of 135210 shares, corresponding to a short interest percentage increase of 1.21%. The days needed to cover the short positions amount to 13.6. The approximate worth of the shares held short is $276.45 million.

With the symbol EVGO, the stock currently has a short interest of 25.70%. The short interest change is 2781419 shares, compared with a short interest percentage change of 9.34%. It would take approximately 9.8 days to cover all the short positions. The shares short value is estimated to be around $34.64 million. The company boasts an average daily volume of 4.07M shares, contributing to a market capitalization of $945.51M.

The stock RXRX has a current short interest of 32.34%. The short interest percentage has experienced an increase of 1.77% while there was a change of 2237630 shares in short interest. The ratio indicating the time required to cover short positions is 2.0. The calculated worth of the shorted shares amounts to around $147.87 million. Trading activity averages at 40.83M shares per day, while the company's market capitalization stands at $2.37B.

Biotech Stocks to Watch

According to our ST Score evaluation, Aurinia Pharmaceuticals Inc (AUPH) emerges as a high-quality stock in the Biotech industry, attaining an impressive score of 63. The stock's profitability, performance, growth, and Piotroski Score are strong. Additionally, it is neutral in terms of financial strength, stock sentiment, and forecast.

Our ST Score also classifies Incyte Corp (INCY) as a high-quality Biotech stock today, presenting a Score of 63. The stock has strong fundamentals in terms of profitability, performance, growth, and Piotroski Score. The financial strength, stock sentiment, and forecast are neutral.

Another stock in the category, Biocryst Pharmaceuticals Inc (BCRX) has the ST Score of 64, which means that the stock carries the potential for higher returns. The stock is strong in profitability and growth. Performance, financial strength, stock sentiment, Piotroski score, and forecast suggest a neutral outlook.

Protagonist Therapeutics Inc (PTGX) stock has the ST Score of 64, which implies that the Biotech company has a high probability of beating the market. The stock's strengths lie in its profitability, performance, financial strength, and Piotroski Score. However, it shows neutral outlook in growth, stock sentiment, and forecast.

Kiniksa Pharmaceuticals International Plc (KNSA) currently has the ST Score of 63, which signifies a huge upward potential. The Biotech stock's strong points are its profitability, performance, growth, and Piotroski Score. The stock's financial strength, stock sentiment, and forecast indicate a neutral outlook.

That's it for today. Thanks for reading. Good luck out there!

Best Regards,

Stocks Telegraph Team

P.S. Want my daily watchlists sent to your cell phone too? Join our WhatsApp Exclusive Community for real-time alerts on hot stocks. Stay ahead with instant updates and exclusive insights!